Welcome to the IPC Psoriasis Masterclass for North America, an exclusive educational opportunity for early- to mid-career dermatologists and other healthcare professionals actively managing and treating psoriasis. Focused on fostering a small-group environment, this FREE program offers an intimate and personalized learning experience, ensuring each participant receives the utmost attention and support.
Over the past eight years, we have successfully hosted the IPC Psoriasis Masterclass worldwide, including the Eastern Mediterranean and Africa, Latin America, Eastern Europe, and Asia, engaging nearly 1,500 participants from an impressive 65 countries. We are bringing this unique program to North America for the fifth time.
This Masterclass is led by an esteemed faculty of international experts boasting extensive experience in psoriasis care. We aim to equip attendees with cutting-edge skills and knowledge to elevate their careers and become leaders in psoriasis.
IPC will cover the cost of your 1-night stay at the Hyatt Regency DFW and provide a reception on Saturday and breakfast on Sunday before the program begins.
Schedule:
Saturday, April 10
13:00 – Registration
14:00 – Program Begins
18:00 – Program Ends & Reception
Sunday, April 11
06:30 – Breakfast
08:00 – Program Begins
12:00 – Program Ends
The Masterclass is limited to 60 participants, selected from those dedicated to advancing their expertise in managing and treating psoriasis. If you are a Dermatologist, Nurse Practitioner, Physician Assistant, or Dermatology Resident from North America with a solid background in dermatology, this program is designed for you.
Brief Summary of the Course
The IPC Psoriasis Masterclass for North America is an intensive, eight-hour educational program designed for early- to mid-career dermatologists and healthcare professionals interested in specializing in psoriasis care. With a focus on fostering a small-group environment, the Masterclass provides a personalized learning experience that empowers participants to excel in their careers and become leaders in psoriasis care.
The agenda has been carefully designed to ensure participants gain the skills and knowledge required to manage patients effectively. Participants will engage in dynamic discussions, interactive Q&A sessions, and invaluable networking opportunities with distinguished experts in the field.
Learning Outcomes
Topics Covered
Prerequisites
The IPC Psoriasis Masterclass is for early- to mid-career dermatologists and other health professionals with a strong foundation in dermatology who make treatment decisions and manage patients with psoriasis.
REGISTRATION – 1:00 pm
WELCOME + INTRODUCTION
Andrew Blauvelt, MD, MBA, Maryland
The Science of Psoriasis: Pathogenesis and Genetics
Christopher Bunick, MD, PhD, Connecticut
Biologics for Psoriasis
Joseph Merola, MD, MMSc, Texas
Early Intervention in Psoriasis
Andrew Blauvelt, MD, MBA, Maryland
Q & A
BREAK
Phenotype Shifts (AD in PsO Patients and PsO in AD patients)
Jeffrey Cohen, MD, MPH, Connecticut
Topical and Oral Therapies for Psoriasis
Christopher Bunick, MD, PhD, Connecticut
Q & A
Case Session 1 (3 cases, 15 minutes each)
Attendees Presentations
Reception and Networking
REGISTRATION – 7:30 am
WELCOME DAY 2
Jeffrey Cohen, MD, MPH , Connecticut
Psoriatic Arthritis for Dermatologists
Alice Gottlieb, MD, PhD, Texas
Cardiometabolic Disease and Psoriasis, Including GLP-1 Use
Joseph Merola, MD, MMSc, Texas
Pustular Psoriasis (GPP/PPP)
Alice Gottlieb, MD, PhD, Texas
Personalized Medicine
Jeffrey Cohen, MD, MPH, Connecticut
The Next Frontier: Remission and Cure of Psoriasis
Andrew Blauvelt, MD, MBA, Maryland
Q&A
BREAK
Case Session 2 (3 cases, 15 minutes each)
Attendees Presentations
Q & A and Open Discussion
Closing Comments and Wrap-up
Andrew Blauvelt, MD, MBA, Maryland
Jeffrey Cohen, MD, MPH, Connecticut
Hyatt Regency DFW International Airport
2334 North International Parkway
DFW Airport, Texas 75621
Check-in: 16:00 | Check-out: 12:00
IPC will pay for a 1-night stay at the Hyatt Regency DFW in Dallas for each participant.
Transportation
Participants are responsible for arranging and financing their air and ground transportation to the event. We recommend booking your flights well in advance to secure the best rates and ensure your travel plans accommodate the entire program.
Ground
The Hyatt Regency DFW International Airport is conveniently located at the Dallas-Fort Worth Airport Terminal C. A 24-hour airport shuttle is offered.
Meals
An evening reception with heavy hors d’oeuvres and drinks will be provided on Saturday, April 10, and breakfast and breaks will be provided on Sunday, April 11.
IPC Jr. Councilor Towhida Noor reviews the psoriasis pipeline: selective TYK2 inhibitors, long-acting IL-17 and IL-23 biologics, and IL-36 blockade in GPP.
IPC Board Member and Treasurer Joel Gelfand, MD, MSCE, is the editor of a new textbook, Psoriasis: An Expert Global Perspective, now available for preorder from Elsevier. He worked with associate editors IPC President Bruce Strober, MD, PhD; IPC Vice President/President-Elect Claudia de la Cruz, MD; and IPC Chief Medical Officer Peter van de Kerkhof, MD, PhD. Nearly 50 authors from 20 countries contributed 30 chapters covering psoriasis from its earliest descriptions through genetics, immunology, and current therapies, with clinical images of psoriasis across diverse skin tones. All royalties support IPC.
PRE-ORDER YOUR COPY
In this video, IPC Councilor Rodrigo Garcia Salinas, MD, a rheumatologist from Argentina, explains how to recognize psoriatic arthritis early, including why joint pain, how long a patient has had psoriasis, and family history can matter more than skin severity alone. He also reviews how imaging helps catch early disease and how to choose treatment based on each patient’s joint, spine, and skin involvement.
IPC President Bruce Strober reviews the link between psoriasis and metabolic disease, drawing on findings from IPC’s recent paper in the Journal of the American Academy of Dermatology (JAAD). He translates this growing body of evidence into five concrete priorities from the 2025 IPC Think Tank for improving cardiometabolic screening and care.
